We report two pediatric patients with recalcitrant staphylococcal infections whose infections resolved when rifampin was added to standard antistaphylococcal therapy. One patient had a post-varicella staphylococcal ulcerative lesion and did not respond to cephalexin alone but did respond when rifampin was added. A second patient had staphylococcal bullous impetigo and did not respond to dicloxacillin or cephalexin but did respond when rifampin was added to the cephalexin. If a patient fails to respond to traditional antistaphylococcal therapy, the addition of rifampin may be beneficial.
Get full access to this article
View all access options for this article.
References
1.
Finch R.Skin and soft-tissue infections. Lancet.1988 ;1:164-168.
2.
Feder HM Jr, Abrahamian LM, Grant-Kels JMIs penicillin still the drug of choice for non-bullous impetigo?Lancet. 1991 ;338:803-805.
3.
Hebert AA, Still JG, Reuman PDComparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children. Pediatr Infect Dis J.1993;12(Suppl.):112-117.
4.
Tomasz A.Multiple-antibiotic-resistant pathogenic bacteria. N Engl J Med.1994;330:1247-1251.
5.
Kapusnik JE, Parenti F., Sande MAThe use of rifampin in staphylococcal infections—a review. J Antimicrob Chemother.1984;13(Suppl.):61-66.
6.
Tsankov NK, Kamarashev JARifampin in dermatology. Int J Derm. 1993;32:401-406.
7.
Farr B., Mandell GLRifampin. Med Clin North Am.1982;66:157-165.
8.
Morris AB, Brown RB, Sands M.Use of rifampin in nonstaphylococcal, nonmycobacterial disease. Antimicrob Agents Chemother.1993;37:1-7.
9.
Traczewski MM , Goldmann DA, Murphy P.In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. Antimicrob Agents Chemother.1983;23:571-576.
10.
VanDerAuwera P., Klastersky J.In vitro study of combination of rifampin with oxacillin against Staphylococcus aureus. J Inf Dis.1983;5(Suppl.):509-513.
11.
VanDerAuwera P., Meunier-Carpentier F., Klastersky J.Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections . Rev InfDis.1983;5(Suppl.):515-522.
Sande MAThe use of rifampin in the treatment of nontuberculous infections: an overview . Rev Inf Dis.1983;5 (Suppl.):339-401.
14.
Chaudhary S. , Bilinsky SA, Hennessy JL, et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days of penicillin vs 10 days of penicillin with rifampin during the final 4 days of therapy. J Pediatr.1985 ; 106:481-486.
15.
Tanz RR, Shulman ST, Barthel MJ, et al. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr.1985;106:876-880.
16.
Tan TQ, Mason EO Jr, Ou C., Kaplan SLUse of intravenous rifampin in neonates with persistent staphylococcal bacteremia . Antimicrob Agents Chemother: 1993;37:2401-2406.
